Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Editorial Comment.

Kaag MG.

J Urol. 2019 Jul;202(1):82. doi: 10.1097/01.JU.0000557734.15067.14. Epub 2019 Jun 7. No abstract available.

PMID:
30925089
2.

Sarcopenia is a reliable predictor of outcomes following radical cystectomy for bladder cancer.

Kaag MG, Raman JD.

Transl Androl Urol. 2018 Dec;7(Suppl 6):S732-S734. doi: 10.21037/tau.2018.09.03. No abstract available.

3.

Capturing Renal Cell Carcinoma Recurrences When Asymptomatic Improves Patient Survival.

Merrill SB, Sohl BS, Hamirani A, Lehman EB, Lehman KK, Kaag MG, Raman JD.

Clin Genitourin Cancer. 2019 Apr;17(2):132-138. doi: 10.1016/j.clgc.2018.11.009. Epub 2018 Nov 22.

PMID:
30563753
4.

Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury.

Bodo S, Campagne C, Thin TH, Higginson DS, Vargas HA, Hua G, Fuller JD, Ackerstaff E, Russell J, Zhang Z, Klingler S, Cho H, Kaag MG, Mazaheri Y, Rimner A, Manova-Todorova K, Epel B, Zatcky J, Cleary CR, Rao SS, Yamada Y, Zelefsky MJ, Halpern HJ, Koutcher JA, Cordon-Cardo C, Greco C, Haimovitz-Friedman A, Sala E, Powell SN, Kolesnick R, Fuks Z.

J Clin Invest. 2019 Feb 1;129(2):786-801. doi: 10.1172/JCI97631. Epub 2019 Jan 14.

5.

Impact of United States Preventive Services Task Force recommendations on prostate biopsy characteristics and disease presentation at a tertiary-care medical center.

Blair BM, Robyak H, Clark JY, Kaag MG, Lehman EB, Raman JD.

Prostate Int. 2018 Sep;6(3):110-114. doi: 10.1016/j.prnil.2018.03.001. Epub 2018 Mar 9.

6.

Topical rectal antiseptic at time of prostate biopsy: how a resident patient safety project has evolved into institutional practice.

Park R, Gyorfi J, Dewan K, Kirimanjeswara G, Clark JY, Kaag MG, Lehman K, Raman JD.

Int Urol Nephrol. 2018 Sep;50(9):1563-1568. doi: 10.1007/s11255-018-1937-3. Epub 2018 Jul 17.

PMID:
30019310
7.

Predicted versus observed 30-day perioperative outcomes using the ACS NSQIP surgical risk calculator in patients undergoing partial nephrectomy for renal cell carcinoma.

Blair BM, Lehman EB, Jafri SM, Kaag MG, Raman JD.

Int Urol Nephrol. 2018 Jul;50(7):1249-1256. doi: 10.1007/s11255-018-1898-6. Epub 2018 Jun 4.

PMID:
29868938
8.

Clinical guidelines: Clearing murky water - a guideline-based approach to haematuria.

Kaag MG, Raman JD.

Nat Rev Urol. 2016 May;13(5):243-4. doi: 10.1038/nrurol.2016.72. Epub 2016 Apr 13. No abstract available.

PMID:
27071454
9.

Critical analysis of 30 day complications following radical nephroureterectomy for upper tract urothelial carcinoma.

Lin YK, Deliere A, Lehman K, Harpster LE, Kaag MG, Raman JD.

Can J Urol. 2014 Aug;21(4):7369-73.

PMID:
25171281
10.

Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward.

Apolo AB, Hoffman V, Kaag MG, Latini DM, Lee CT, Rosenberg JE, Knowles M, Theodorescu D, Czerniak BA, Efstathiou JA, Albert ML, Sridhar SS, Margulis V, Matin SF, Galsky MD, Hansel D, Kamat AM, Flaig TW, Smith AB, Messing E, Zipursky Quale D, Lotan Y.

Urol Oncol. 2015 Feb;33(2):53-64. doi: 10.1016/j.urolonc.2014.06.013. Epub 2014 Jul 25. Review.

PMID:
25065704
11.

Editorial Comment from Dr Kaag and Dr Raman to Obesity and prognosis in muscle-invasive bladder cancer: the continuing controversy.

Kaag MG, Raman JD.

Int J Urol. 2014 Nov;21(11):1113. doi: 10.1111/iju.12552. Epub 2014 Jul 8. No abstract available.

12.

Comparative effects of two different forms of selenium on oxidative stress biomarkers in healthy men: a randomized clinical trial.

Richie JP Jr, Das A, Calcagnotto AM, Sinha R, Neidig W, Liao J, Lengerich EJ, Berg A, Hartman TJ, Ciccarella A, Baker A, Kaag MG, Goodin S, DiPaola RS, El-Bayoumy K.

Cancer Prev Res (Phila). 2014 Aug;7(8):796-804. doi: 10.1158/1940-6207.CAPR-14-0042. Epub 2014 Jun 17.

13.

Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States.

Apolo AB, Kim JW, Bochner BH, Steinberg SM, Bajorin DF, Kelly WK, Agarwal PK, Koppie TM, Kaag MG, Quinn DI, Vogelzang NJ, Sridhar SS.

Urol Oncol. 2014 Jul;32(5):637-44. doi: 10.1016/j.urolonc.2013.12.012. Epub 2014 May 16.

14.

Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases.

Pinkhasov GI, Lin YK, Palmerola R, Smith P, Mahon F, Kaag MG, Dagen JE, Harpster LE, Reese CT, Raman JD.

BJU Int. 2012 Aug;110(3):369-74. doi: 10.1111/j.1464-410X.2011.10926.x. Epub 2012 Feb 7.

15.

Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma.

Silberstein JL, Power NE, Savage C, Tarin TV, Favaretto RL, Su D, Kaag MG, Herr HW, Dalbagni G.

J Urol. 2012 Feb;187(2):429-34. doi: 10.1016/j.juro.2011.09.150. Epub 2011 Dec 15.

16.

Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy.

Kaag MG, Milowsky MI, Dalbagni G, Thompson RH, Katz D, Reuter VE, Herr HW, Bajorin D, Bochner BH.

BJU Int. 2011 Oct;108(8 Pt 2):E272-7. doi: 10.1111/j.1464-410X.2010.09981.x. Epub 2011 Feb 14.

17.

Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma.

Adamy A, Chong KT, Chade D, Costaras J, Russo G, Kaag MG, Bernstein M, Motzer RJ, Russo P.

J Urol. 2011 Feb;185(2):433-8. doi: 10.1016/j.juro.2010.09.100. Epub 2010 Dec 17.

PMID:
21167521
18.

Prostate cancer topography and patterns of lymph node metastasis.

Tokuda Y, Carlino LJ, Gopalan A, Tickoo SK, Kaag MG, Guillonneau B, Eastham JA, Scher HI, Scardino PT, Reuter VE, Fine SW.

Am J Surg Pathol. 2010 Dec;34(12):1862-7. doi: 10.1097/PAS.0b013e3181fc679e.

19.

Radical nephrectomy with vena caval thrombectomy: a contemporary experience.

Kaag MG, Toyen C, Russo P, Cronin A, Thompson RH, Schiff J, Bernstein M, Bains M.

BJU Int. 2011 May;107(9):1386-93. doi: 10.1111/j.1464-410X.2010.09661.x. Epub 2010 Sep 30.

20.

Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy.

Kaag MG, O'Malley RL, O'Malley P, Godoy G, Chen M, Smaldone MC, Hrebinko RL, Raman JD, Bochner B, Dalbagni G, Stifelman MD, Taneja SS, Huang WC.

Eur Urol. 2010 Oct;58(4):581-7. doi: 10.1016/j.eururo.2010.06.029. Epub 2010 Jun 25.

Supplemental Content

Support Center